340 related articles for article (PubMed ID: 25884309)
1. Plasma clusterin as a candidate pre-diagnosis marker of colorectal cancer risk in the Florence cohort of the European Prospective Investigation into Cancer and Nutrition: a pilot study.
Bertuzzi M; Marelli C; Bagnati R; Colombi A; Fanelli R; Saieva C; Ceroti M; Bendinelli B; Caini S; Airoldi L; Palli D
BMC Cancer; 2015 Feb; 15():56. PubMed ID: 25884309
[TBL] [Abstract][Full Text] [Related]
2. Identification of adipophilin as a potential plasma biomarker for colorectal cancer using label-free quantitative mass spectrometry and protein microarray.
Matsubara J; Honda K; Ono M; Sekine S; Tanaka Y; Kobayashi M; Jung G; Sakuma T; Nakamori S; Sata N; Nagai H; Ioka T; Okusaka T; Kosuge T; Tsuchida A; Shimahara M; Yasunami Y; Chiba T; Yamada T
Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2195-203. PubMed ID: 21828233
[TBL] [Abstract][Full Text] [Related]
3. Analysis of acute-phase proteins, AHSG, C3, CLI, HP and SAA, reveals distinctive expression patterns associated with breast, colorectal and lung cancer.
Dowling P; Clarke C; Hennessy K; Torralbo-Lopez B; Ballot J; Crown J; Kiernan I; O'Byrne KJ; Kennedy MJ; Lynch V; Clynes M
Int J Cancer; 2012 Aug; 131(4):911-23. PubMed ID: 21953030
[TBL] [Abstract][Full Text] [Related]
4. Identification and validation of novel candidate protein biomarkers for the detection of human gastric cancer.
Humphries JM; Penno MA; Weiland F; Klingler-Hoffmann M; Zuber A; Boussioutas A; Ernst M; Hoffmann P
Biochim Biophys Acta; 2014 May; 1844(5):1051-8. PubMed ID: 24512919
[TBL] [Abstract][Full Text] [Related]
5. Plasma biomarker discovery and validation for colorectal cancer by quantitative shotgun mass spectrometry and protein microarray.
Murakoshi Y; Honda K; Sasazuki S; Ono M; Negishi A; Matsubara J; Sakuma T; Kuwabara H; Nakamori S; Sata N; Nagai H; Ioka T; Okusaka T; Kosuge T; Shimahara M; Yasunami Y; Ino Y; Tsuchida A; Aoki T; Tsugane S; Yamada T
Cancer Sci; 2011 Mar; 102(3):630-8. PubMed ID: 21199170
[TBL] [Abstract][Full Text] [Related]
6. Mass spectrometry assays of plasma biomarkers to predict radiographic progression of knee osteoarthritis.
Ritter SY; Collins J; Krastins B; Sarracino D; Lopez M; Losina E; Aliprantis AO
Arthritis Res Ther; 2014 Oct; 16(5):456. PubMed ID: 25287745
[TBL] [Abstract][Full Text] [Related]
7. Revelation of Proteomic Indicators for Colorectal Cancer in Initial Stages of Development.
Kopylov AT; Stepanov AA; Malsagova KA; Soni D; Kushlinsky NE; Enikeev DV; Potoldykova NV; Lisitsa AV; Kaysheva AL
Molecules; 2020 Jan; 25(3):. PubMed ID: 32023884
[No Abstract] [Full Text] [Related]
8. Plasma C-reactive protein and risk of colorectal cancer in a nested case-control study: Japan Public Health Center-based prospective study.
Otani T; Iwasaki M; Sasazuki S; Inoue M; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):690-5. PubMed ID: 16614110
[TBL] [Abstract][Full Text] [Related]
9. Quantitative proteomic analysis exploring progression of colorectal cancer: Modulation of the serpin family.
Peltier J; Roperch JP; Audebert S; Borg JP; Camoin L
J Proteomics; 2016 Oct; 148():139-48. PubMed ID: 27492143
[TBL] [Abstract][Full Text] [Related]
10. Clusterin in stool: a new biomarker for colon cancer screening?
Pucci S; Bonanno E; Sesti F; Mazzarelli P; Mauriello A; Ricci F; Zoccai GB; Rulli F; Galatà G; Spagnoli LG
Am J Gastroenterol; 2009 Nov; 104(11):2807-15. PubMed ID: 19623170
[TBL] [Abstract][Full Text] [Related]
11. Proteomic profiling reveals α1-antitrypsin, α1-microglobulin, and clusterin as preeclampsia-related serum proteins in pregnant women.
Hsu TY; Hsieh TT; Yang KD; Tsai CC; Ou CY; Cheng BH; Wong YH; Hung HN; Chou AK; Hsiao CC; Lin H
Taiwan J Obstet Gynecol; 2015 Oct; 54(5):499-504. PubMed ID: 26522099
[TBL] [Abstract][Full Text] [Related]
12. Qualification and Verification of Serological Biomarker Candidates for Lung Adenocarcinoma by Targeted Mass Spectrometry.
Wu HY; Goan YG; Chang YH; Yang YF; Chang HJ; Cheng PN; Wu CC; Zgoda VG; Chen YJ; Liao PC
J Proteome Res; 2015 Aug; 14(8):3039-50. PubMed ID: 26120931
[TBL] [Abstract][Full Text] [Related]
13. Identification of Differentially Expressed Proteins in the Serum of Colorectal Cancer Patients Using 2D-DIGE Proteomics Analysis.
Lim LC; Looi ML; Zakaria SZ; Sagap I; Rose IM; Chin SF; Jamal R
Pathol Oncol Res; 2016 Jan; 22(1):169-77. PubMed ID: 26463353
[TBL] [Abstract][Full Text] [Related]
14. Head-to-Head Comparison and Evaluation of 92 Plasma Protein Biomarkers for Early Detection of Colorectal Cancer in a True Screening Setting.
Chen H; Zucknick M; Werner S; Knebel P; Brenner H
Clin Cancer Res; 2015 Jul; 21(14):3318-26. PubMed ID: 26015516
[TBL] [Abstract][Full Text] [Related]
15. Proteomics of colorectal cancer: overview of discovery studies and identification of commonly identified cancer-associated proteins and candidate CRC serum markers.
Jimenez CR; Knol JC; Meijer GA; Fijneman RJ
J Proteomics; 2010 Sep; 73(10):1873-95. PubMed ID: 20601272
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of conditioned media from ovarian cancer cell lines identifies novel candidate markers of epithelial ovarian cancer.
Gunawardana CG; Kuk C; Smith CR; Batruch I; Soosaipillai A; Diamandis EP
J Proteome Res; 2009 Oct; 8(10):4705-13. PubMed ID: 19663500
[TBL] [Abstract][Full Text] [Related]
17. Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach.
Xue H; Lü B; Zhang J; Wu M; Huang Q; Wu Q; Sheng H; Wu D; Hu J; Lai M
J Proteome Res; 2010 Jan; 9(1):545-55. PubMed ID: 19924834
[TBL] [Abstract][Full Text] [Related]
18. Low folate levels are associated with reduced risk of colorectal cancer in a population with low folate status.
Gylling B; Van Guelpen B; Schneede J; Hultdin J; Ueland PM; Hallmans G; Johansson I; Palmqvist R
Cancer Epidemiol Biomarkers Prev; 2014 Oct; 23(10):2136-44. PubMed ID: 25063522
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive Detection of Colorectal Carcinomas Using Serum Protein Biomarkers.
Ivancic MM; Megna BW; Sverchkov Y; Craven M; Reichelderfer M; Pickhardt PJ; Sussman MR; Kennedy GD
J Surg Res; 2020 Feb; 246():160-169. PubMed ID: 31586890
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of serum clusterin isoforms in colorectal cancer.
Rodríguez-Piñeiro AM; de la Cadena MP; López-Saco A; Rodríguez-Berrocal FJ
Mol Cell Proteomics; 2006 Sep; 5(9):1647-57. PubMed ID: 16854844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
